Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Ventana Medical Systems and Boehringer Ingelheim have entered into an agreement to collaborate on the development of companion diagnostic tests for Boehringer Ingelheim oncology programs.
Terumo BCT has received FDA 510(k) clearance for single-needle therapeutic plasma exchange (SN-TPE) on its Spectra Optia apheresis system. This option gives therapeutic apheresis operators the ability to convert to SN-TPE at the beginning or at any time during the procedure, depending on patient needs.
NanoString Technologies has received FDA 510(k) clearance for its Prosigna breast cancer prognostic gene signature assay. Based on the PAM50 gene signature, Prosigna is the company’s first FDA-cleared in vitro diagnostic assay and uses the gene-expression profile of cells found in breast cancer tissue to assess a patient’s risk of distant recurrence of disease. The Prosigna assay is performed using the nCounter Dx analy
Enzo Life Sciences’ high-efficiency BioArray conversion kits for detecting 5-mC and 5-hmC modifications (Express DNA methylation kit, blood and tissue DNA methylation kit, and BioArray 5-hmC methylation kit) allow for resolution of single-nucleotide changes without introducing DNA damage. Features such as capacity for multiple sample inputs, rapid processing time, and high-conversion efficiency rate provide enhanced flexibility without sacrificing performance.
The Allegra X-5 air-cooled benchtop centrifuge from Beckman Coulter Life Sciences is designed specifically for clinical sample preparation. Bundled packages, which include swinging bucket rotors and common adapters, enable fast and convenient setup and are offered for a range of clinical sample prep applications.
Clean Collect blood culture kits, available from Stone Medical, prevent contamination of blood cultures using a patented diversion method.
Wheaton CryoELITE tissue vials feature a wide-mouth opening, 5-mL capacity, and high-integrity closure. The vials offer researchers who work with biological tissue sections ease of use, convenience, and security.
PAML, through a partnership with Verinata Health, is now offering the Verifi prenatal test for all patients within the network desiring noninvasive prenatal testing to detect Down syndrome, Edwards syndrome, Patau syndrome, and sex chromosome abnormalities, the most common genetic abnormalities tested for during pregnancy.
SciGene’s new sodium thiocyanate pretreatment reagent, a convenient 1-M liquid formulation of NaSCN for pretreating tissue samples prior to application of nucleic acid probes for cytogenetic assays, joins an expanding line of FISH slide-processing products from SciGene.
Smart Imaging Technologies’ Interactive Web Reports for its Simagis Live Digital Pathology servers make it possible for pathologists to complete and sign off digital cases, create professional, media-rich reports from digital slides, and share them instantly with clients, colleagues, or patients.
